IL13 and asthma: Wang et al. showed that curcumin-solid lipid nanoparticles, administered by IP injection, effectively suppressed airway hyperresponsiveness, inflammatory cell infiltration and expression of IL-4 and IL-13 in bronchoalveolar lavage fluid in an asthma animal model [38].